Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(AstraZeneca) Feb 19, 2018 - AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent...
Read Article
(Business Insider) Feb 15, 2018 - Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after treatment with a platinum-containing...
Read Article
Latest Articles
February 20, 2018
February 20, 2018
February 15, 2018
February 15, 2018
February 14, 2018
February 14, 2018
February 13, 2018
February 12, 2018
View More
News Commentary
Editor Image
06 Mar, 2017 | by H. Jack West, MD
I'm dubious about a 62% specificity. The test doesn't conclusively rule out...
View Comment
Editor Image
24 Mar, 2017 | by H. Jack West, MD
It's striking that we've needed yet another revision of the NCCN guidelines in...
View Comment
View More
OBR Green
There are no Lung (includes NSCLC, SCLC, Mesothelioma) OBR Green articles.
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.